Researchers review current evidence on Candida auris, an emerging multidrug-resistant yeast

The companies signed an MOU to introduce Immuncell-LC in the Indonesian market. Credit: Copyright ⓒ 2024 GC Cell. All rights reserved. GC Cell has signed

I2o Ther­a­peu­tics CEO Kurt Graves set out on Thurs­day to make a case to a pan­el of the FDA’s ex­pert ad­vi­sors that the ben­e­fits of

At the recent American Society of Clinical Oncology (ASCO) annual meeting, groundbreaking advancements in cancer therapy were highlighted, particularly in the treatment of large B-cell